GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AegirBio AB (GREY:AEGBF) » Definitions » FCF Yield %

AegirBio AB (AegirBio AB) FCF Yield % : -195.78 (As of May. 24, 2024)


View and export this data going back to 2023. Start your Free Trial

What is AegirBio AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, AegirBio AB's Trailing 12-Month Free Cash Flow is $-3.37 Mil, and Market Cap is $1.75 Mil. Therefore, AegirBio AB's FCF Yield % for today is -195.78%.

The historical rank and industry rank for AegirBio AB's FCF Yield % or its related term are showing as below:

AEGBF' s FCF Yield % Range Over the Past 10 Years
Min: -412.49   Med: -73.46   Max: -0.44
Current: -195.78


During the past 4 years, the highest FCF Yield % of AegirBio AB was -0.44%. The lowest was -412.49%. And the median was -73.46%.

AEGBF's FCF Yield % is ranked worse than
95.17% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -2.775 vs AEGBF: -195.78

AegirBio AB's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


AegirBio AB FCF Yield % Historical Data

The historical data trend for AegirBio AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AegirBio AB FCF Yield % Chart

AegirBio AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
FCF Yield %
- - - -

AegirBio AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -94.30 -106.43 -133.79

Competitive Comparison of AegirBio AB's FCF Yield %

For the Medical Devices subindustry, AegirBio AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AegirBio AB's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AegirBio AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where AegirBio AB's FCF Yield % falls into.



AegirBio AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

AegirBio AB's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.727 / 0
=N/A%

AegirBio AB's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.136 * 4 / 3.396459
=-133.79%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AegirBio AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


AegirBio AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of AegirBio AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


AegirBio AB (AegirBio AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company that offers tests to monitor and optimize the dosage of biological drugs via its patented technology platform. The company's products include Monator - drug monitoring of tysabri in MS, Veritope, and Magniareader.

AegirBio AB (AegirBio AB) Headlines

No Headlines